Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor treatment options, emphasizing the need for novel therapeutic targets. Hub proteins have high connectivity (i.e., many interaction partners) and often act as central biological regulators. Here, we aimed to identify hub proteins with potential...
Foram Vyas, Virginie Defamie, Kelvin Yeung et al.· Cancer Research· 0 citations
Cellular heterogeneity in pancreatic ductal adenocarcinoma (PDAC) poses significant challenges for disease prognosis and limits the effectiveness of therapeutic strategies implemented in recent multicenter subtype-based clinical trials worldwide. A hallmark of PDAC is extensive intratumoral heterogeneity, which is la...
Xue-Yan Wu, L. Klein, M. Tu et al.· Cancer Research· 0 citations
A lineage-resolved monolayer culture system is established that enables propagation of primary human mammary epithelial populations while preserving lineage identity across passages and provides a functional framework for determining critical events in the expansion of genomically altered mammary epithelial cells in th...